We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Adient (ADNT) Down 12.6% Since Last Earnings Report: Can It Rebound?
Read MoreHide Full Article
A month has gone by since the last earnings report for Adient (ADNT - Free Report) . Shares have lost about 12.6% in that time frame, underperforming the S&P 500.
But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Adient due for a breakout? Well, first let's take a quick look at the latest earnings report in order to get a better handle on the recent drivers for Adient before we dive into how investors and analysts have reacted as of late.
Adient Q1 Earnings Top Expectations
Adient reported adjusted EPS of 35 cents for the first quarter of fiscal 2026. Earnings rose from 27 cents recorded in the year-ago period and beat the Zacks Consensus Estimate of 20 cents. The company generated net sales of $3.64 billion, which increased 4.3% year over year and beat the Zacks Consensus Estimate of $3.48 billion.
Segmental Performance
Adient currently operates via three reportable segments: Americas, including North America and South America; Europe, which includes the Middle East and Africa (EMEA); and Asia Pacific/China (Asia).
In the reported quarter, the Americas segment recorded revenues of $1.64 billion, which rose 1.9% from the year-ago period and topped the Zacks Consensus Estimate of $1.54 billion. The segment recorded an adjusted EBITDA of $80 million, which decreased from $85 million recorded in the prior-year quarter due to volume headwinds and an increase in launch costs. The metric, however, beat the Zacks Consensus Estimate of $66 million.
The EMEA segment registered revenues of $1.21 billion, which increased 6.7% year over year and topped the Zacks Consensus Estimate of $1.14 billion. The segment recorded an adjusted EBITDA of $34 million, which rose from $22 million generated in the year-ago period due to enhanced operational efficiencies and favorable material margin. The metric also topped the Zacks Consensus Estimate of $24.66 million.
In the fiscal first quarter, revenues in the Asia segment totaled $819 million, which grew from $772 million in the first quarter of fiscal 2025 and topped the Zacks Consensus Estimate of $797 million. The segment recorded an adjusted EBITDA of $115 million, up from $111 million recorded in the corresponding quarter of fiscal 2025 due to favorable equity income and forex movement. The figure also beat the Zacks Consensus Estimate of $111 million.
Financial Position
Adient had cash and cash equivalents of $855 million as of Dec. 31, 2025, compared with $958 million as of Sept. 30, 2025.
As of Dec. 31, 2025, long-term debt amounted to $2.38 billion.
Capital expenditures totaled $65 million compared with $64 million in the prior-year quarter.
Fiscal 2026 Outlook
Adient now envisions fiscal 2026 revenues to be $14.6 billion, up from the previous estimate of $14.4 billion. Adjusted EBITDA is estimated to be $880 million, up from the prior estimate of $845 million. Equity income is projected to be $70 million. Free cash flow is now anticipated to be $125 million, up from the previous estimate of $90 million. Capex is estimated to be $300 million.
How Have Estimates Been Moving Since Then?
Since the earnings release, investors have witnessed a downward trend in estimates revision.
The consensus estimate has shifted -35.97% due to these changes.
VGM Scores
At this time, Adient has a great Growth Score of A, though it is lagging a bit on the Momentum Score front with a B. Charting a somewhat similar path, the stock was allocated a score of A on the value side, putting it in the top quintile for value investors.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, Adient has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
Image: Bigstock
Adient (ADNT) Down 12.6% Since Last Earnings Report: Can It Rebound?
A month has gone by since the last earnings report for Adient (ADNT - Free Report) . Shares have lost about 12.6% in that time frame, underperforming the S&P 500.
But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Adient due for a breakout? Well, first let's take a quick look at the latest earnings report in order to get a better handle on the recent drivers for Adient before we dive into how investors and analysts have reacted as of late.
Adient Q1 Earnings Top Expectations
Adient reported adjusted EPS of 35 cents for the first quarter of fiscal 2026. Earnings rose from 27 cents recorded in the year-ago period and beat the Zacks Consensus Estimate of 20 cents. The company generated net sales of $3.64 billion, which increased 4.3% year over year and beat the Zacks Consensus Estimate of $3.48 billion.
Segmental Performance
Adient currently operates via three reportable segments: Americas, including North America and South America; Europe, which includes the Middle East and Africa (EMEA); and Asia Pacific/China (Asia).
In the reported quarter, the Americas segment recorded revenues of $1.64 billion, which rose 1.9% from the year-ago period and topped the Zacks Consensus Estimate of $1.54 billion. The segment recorded an adjusted EBITDA of $80 million, which decreased from $85 million recorded in the prior-year quarter due to volume headwinds and an increase in launch costs. The metric, however, beat the Zacks Consensus Estimate of $66 million.
The EMEA segment registered revenues of $1.21 billion, which increased 6.7% year over year and topped the Zacks Consensus Estimate of $1.14 billion. The segment recorded an adjusted EBITDA of $34 million, which rose from $22 million generated in the year-ago period due to enhanced operational efficiencies and favorable material margin. The metric also topped the Zacks Consensus Estimate of $24.66 million.
In the fiscal first quarter, revenues in the Asia segment totaled $819 million, which grew from $772 million in the first quarter of fiscal 2025 and topped the Zacks Consensus Estimate of $797 million. The segment recorded an adjusted EBITDA of $115 million, up from $111 million recorded in the corresponding quarter of fiscal 2025 due to favorable equity income and forex movement. The figure also beat the Zacks Consensus Estimate of $111 million.
Financial Position
Adient had cash and cash equivalents of $855 million as of Dec. 31, 2025, compared with $958 million as of Sept. 30, 2025.
As of Dec. 31, 2025, long-term debt amounted to $2.38 billion.
Capital expenditures totaled $65 million compared with $64 million in the prior-year quarter.
Fiscal 2026 Outlook
Adient now envisions fiscal 2026 revenues to be $14.6 billion, up from the previous estimate of $14.4 billion. Adjusted EBITDA is estimated to be $880 million, up from the prior estimate of $845 million. Equity income is projected to be $70 million. Free cash flow is now anticipated to be $125 million, up from the previous estimate of $90 million. Capex is estimated to be $300 million.
How Have Estimates Been Moving Since Then?
Since the earnings release, investors have witnessed a downward trend in estimates revision.
The consensus estimate has shifted -35.97% due to these changes.
VGM Scores
At this time, Adient has a great Growth Score of A, though it is lagging a bit on the Momentum Score front with a B. Charting a somewhat similar path, the stock was allocated a score of A on the value side, putting it in the top quintile for value investors.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, Adient has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.